Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: Two cases

Abstract

We present two cases of nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine. We discuss the initial presentation, investigation and management of these patients along with a discussion around the current evidence base for vaccine-induced nephrotic syndrome.